For citations:
Zyryanov S.K., Dyakov I.N. Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(3):422-430. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.211
Views PDF (Rus): 261
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 